SRN Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,241
Closed -$719K 96
2022
Q3
$719K Sell
10,241
-2,614
-20% -$205K 0.6% 72
2022
Q2
$1.03M Sell
12,855
-2,154
-14% -$168K 0.72% 55
2022
Q1
$1.14M Buy
15,009
+212
+1% +$16.8K 0.5% 83
2021
Q4
$1.26M Buy
+14,797
New +$1.16M 0.45% 88

Other funds holding CL

SRN Advisors's CL Position: Q4 2022 in Review

SRN Advisors sold out of Colgate-Palmolive (CL) in Q4 2022, closing a stake of 10,241 shares — an estimated $719K sold.

SRN Advisors first reported a position in CL in Q4 2021 and held it in 4 quarters. The position peaked at $1.26M in Q4 2021. 1,698 funds tracked by Wall St. Rank hold CL as of Q4 2022.

  • SRN Advisors reported no remaining Colgate-Palmolive position as of Q4 2022 after selling out during the quarter.
  • SRN Advisors sold 10,241 Colgate-Palmolive shares in Q4 2022, an estimated $719K.
  • SRN Advisors first reported a position in Colgate-Palmolive in Q4 2021 and held it in 4 quarters.
  • SRN Advisors's Colgate-Palmolive position peaked at $1.26M in Q4 2021.
  • 1,698 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2022.

Based on SRN Advisors's 13F filing for Q4 2022, filed 14 Jun 2024.